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ABSTRACT
Cellular ATP is mainly generated through mitochondrial
oxidative phosphorylation, which is dependent on mitochondrial
DNA (mtDNA). We have previously demonstrated the impor-
tance of oocyte mtDNA for porcine and human fertilization.
However, the role of nuclear-encoded mitochondrial replication
factors during oocyte and embryo development is not yet
understood. We have analyzed two key factors, mitochondrial
transcription factor A (TFAM) and polymerase gamma (POLG),
to determine their role in oocyte and early embryo development.
Competent and incompetent oocytes, as determined by brilliant
cresyl blue (BCB) dye, were assessed intermittently during the
maturation process for TFAM and POLG mRNA using real-time
RT-PCR, for TFAM and POLG protein using immunocytochem-
istry, and for mtDNA copy number using real-time PCR. Analysis
was also carried out following treatment of maturing oocytes
with the mtDNA replication inhibitor, 2’,3’-dideoxycytidine
(ddC). Following in vitro fertilization, preimplantation embryos
were also analyzed. Despite increased levels of TFAM and POLG
mRNA and protein at the four-cell stage, no increase in mtDNA
copy number was observed in early preimplantation develop-
ment. To compensate for this, mtDNA appeared to be replicated
during oocyte maturation. However, significant differences in
nuclear-encoded regulatory protein expression were observed
between BCB+ and BCB– oocytes and between untreated oocytes
and those treated with ddC. These changes resulted in delayed
mtDNA replication, which correlated to reduced fertilization
and embryonic development. We therefore conclude that
adherence to the regulation of the timing of mtDNA replication
during oocyte maturation is essential for successful embryonic
development.
embryo, fertilization, gene regulation, oocyte development
INTRODUCTION
It has previously been demonstrated that the ATP content of
individual embryonic blastomeres is correlated to their
mitochondrial content [1], suggesting that mitochondrially
derived ATP is important during early embryogenesis. Indeed,
aggregation of active mitochondria has been reported around
the pronuclei of fertilized oocytes and/or around the nuclei of
cleavage-stage embryos in many species, including the monkey
[2], hamster [3, 4], mouse [5], and human [6]. Clustering of
mitochondria around the nuclear material has also been
reported during oocyte maturation in the cow [7], mouse [8],
and pig [9], and a significant increase in ATP levels during
bovine in vitro maturation (IVM) is associated with higher
quality oocytes producing significantly higher blastocyst rates
[7]. ATP levels have also been linked to fertilization outcome
in humans, with an estimated minimum requirement of 2 pmol
ATP for successful fertilization [10].
Although ATP can be generated through a variety of
processes, the most efficient method is oxidative phosphoryla-
tion (OXPHOS) via the mitochondrial electron transfer chain
(ETC). This is vital for many cell types, including oocytes [11].
The ETC is located within the inner mitochondrial membrane
and consists of five enzyme complexes each containing multiple
subunits. Electrons flow through the first four complexes,
releasing protons from the mitochondria. Re-entry of the
protons down the newly produced gradient results in the
production of ATP. The ETC is unique in that its complexes
consist of both nuclear- and mitochondrially encoded subunits.
In the pig, the mitochondrial genome (mtDNA) is 16.6 kb in
size [12] and encodes 13 subunits of the ETC. It also encodes 22
tRNAs and 2 rRNAs that are necessary for mRNA expression.
Replication of mtDNA is dependent on nuclear-encoded
transcription and replication factors being translocated to the
mitochondria [13]. It utilizes an RNA primer generated through
transcription by mitochondrial transcription factor A (TFAM)
[14] and the mitochondrial-specific polymerase gamma [15],
consisting of catalytic (POLG) and accessory (POLG2)
subunits [16]. These two factors regulate mtDNA copy
number, which is correlated to the OXPHOS requirements
for specific cells [17]. The replication of mtDNA occurs
throughout oocyte growth in many species [18, 19], and reports
on the frog [20], mouse [21, 22], and shrimp [23] suggest that
no mtDNA replication occurs in the early cleavage stages of
embryogenesis. Absence of mtDNA replication until the
blastocyst stage was recently confirmed in the mouse [24],
and has also been reported in cattle [25]. However, one report
suggests that a short burst of mtDNA replication takes place in
mouse two-cell-only embryos, although there was no increase
in mtDNA copy number [26].
Limited mtDNA replication during preimplantation devel-
opment results in a progressive decrease in mtDNA content in
cleaving blastomeres. Blastomeres in later-staged embryos,
therefore, contain very low levels of mtDNA from which
replication can be propagated. Once gastrulation has taken
place, the inner cell mass (ICM) cells clonally expand their
mtDNA to match the OXPHOS demands of the cells that they
will differentiate into [27]. The segregation process increases
the likelihood that adult cells derived from the same blastomere
will possess the same mtDNA sequence [28]. The lack of
mtDNA replication during preimplantation development sug-
gests that mtDNA copy number needs to be amplified to
sufficient levels prior to fertilization. Evidence in various
mammalian species suggests that preimplantation embryonic
mtDNA composition is dependent on the number of oocyte
mtDNA copies present at fertilization, constituting an invest-
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ment until mtDNA replication is initiated postimplantation. A
critical threshold of approximately 100 000 copies in the
mature oocyte has therefore been proposed for the mouse [22],
pig [29], and human [30, 31], suggesting that mtDNA copy
number may be an indicator of oocyte competence.
Oocyte developmental competence can be assessed by the
activity of glucose-6-phosphate dehydrogenase (G6PD). Loss
of expression of G6PD is associated with oocytes reaching
competency. These oocytes fail to enzymatically break down
the dye, brilliant cresyl blue (BCB) [32, 33], and thus stain
positively (BCB
þ
). Oocytes not having reached competency
are colorless (BCB) due to the continued expression of G6PD,
which breaks down the BCB dye. In the pig, competent BCB
þ
oocytes contain more copies of mtDNA, and are more likely to
fertilize than incompetent BCB oocytes [29]. However,
supplementation of BCB oocytes with mitochondria from
BCB
þ
oocytes, and subsequent improved fertilization outcome,
again demonstrates the association between mitochondrial
number and fertilization outcome [29].
Here, we have investigated the importance of mtDNA
replication during pig early embryogenesis through TFAM and
POLG expression and mtDNA copy number analysis. Through
BCB selection, we have further tested the hypothesis that
oocyte mtDNA replication, and, therefore, oocyte competence,
is dependent on correct expression of TFAM and POLG.
Finally, we have demonstrated the importance of mtDNA
replication for successful oocyte maturation using the inhibitor,
20,30-dideoxycytidine (ddC) [34].
MATERIALS AND METHODS
All chemicals and reagents used were purchased from Sigma Chemical
Company (Poole, UK) unless otherwise stated.
Oocyte Retrieval
Ovaries were collected from a slaughterhouse in PBS supplemented with 75
lg/ml potassium penicillin G and 50 lg/ml streptomycin sulphate. They were
rinsed three times with PBS at 398C and transferred to a laminar-flow hood for
cumulus oocyte complex aspiration from follicles with a diameter of 3–6 mm.
Aspirated oocytes were transferred to a 15-ml conical tube containing 1 ml
basic oocyte culture media consisting of TCM-199 with Earle salts and sodium
bicarbonate, supplemented with 25 mM hepes, 3 mM L-glutamine, 0.1% (w/v)
BSA, 0.57 mM cysteine, 50 IU/ml penicillin, and 50 lg/ml streptomycin.
In Vitro Maturation of Oocytes
Oocytes were matured in 500 ll of IVM media under equilibrated mineral
oil at 398C, 5% CO
2
in air. IVM media consisted of basic oocyte culture media
supplemented with 10 ng/ml epidermal growth factor (EGF), 0.5 lg/ml
luteinizing hormone and 50 ng/ml follicle-stimulating hormone [35]. For the
first 16 h of IVM, the media was further supplemented with 5 lg/ml
cycloheximide (CHX). Oocytes were then washed in basic oocyte culture
media and matured in IVM media without CHX for a further 28–30 h before
fertilization [35]. Oocytes to be analyzed during maturation were matured in
IVM media without CHX for 44–46 h, with one media change.
BCB Test
Oocytes were washed three times in modified Dulbecco PBS (DPBSm;
Dulbecco PBS supplemented with 0.4% [w/v] BSA, 0.34 mM pyruvate, 5.5 mM
glucose, 50 IU/ml penicillin, and 50 lg/ml streptomycin). Oocytes were treated
with 13 lM BCB diluted in DPBSm at 398C, 5% CO
2
in air for 90 min. After
treatment, the oocytes were transferred to DPBSm and washed three times. During
the washing procedure, the oocytes were examined under a stereomicroscope and
classified as either having stained blue (BCBþ) or remained colorless (BCB).
20,30-dideoxycytidine Treatment
Selected untreated oocytes were cultured in IVM media supplemented with
10 lM ddC. Being a nucleoside analogue, ddC can be incorporated into
mtDNA molecules and synthesized in place of the normal nucleoside.
However, lack of a 30 OH group prevents addition of subsequent nucleosides,
resulting in termination of the DNA chain [36]. Replication is further inhibited
by failure of the POLG exonuclease to remove the ddC [37]. Oocytes were
treated for the entire maturation period, with one media change on Day 2, as for
nontreated oocytes.
Sperm Preparation
Sperm were obtained from purebred boars supplied by JSR (Selby, UK).
Samples were centrifuged at 1500 rpm for 5 min. The supernatant was then
removed and the pellet resuspended in 3 ml of sperm preparation media (DPBS
supplemented with 1 mg/ml BSA, 100 lg/ml potassium penicillin G, and 75
lg/ml streptomycin) followed by centrifugation at 1200 rpm for 5 min. The
new pellet was then resuspended in 2 ml of sperm preparation media and
layered onto a 95%:45% Percoll gradient before centrifugation at 1500 rpm for
25 min. The 90% fraction was resuspended in 2 ml modified Tris-buffered





O, 20 mM Tris, and 5 mM sodium pyruvate supplemented
with 0.1% (w/v) BSA, 20 lM adenosine, and 0.2 mM glutathione [35]. The
90% sperm sample was then centrifuged at 1500 rpm for 5 min and the pellet
resuspended in 1 ml mTBM. Sperm counts were performed and samples were
diluted to a concentration of 23 106/ml.
In Vitro Fertilization
Following IVM, oocytes were washed three times in mTBM and cumulus
cells were removed by vortexing for 20 sec followed by pipetting through a fine
pipette. Oocytes were then placed in 50 ll drops of mTBM under mineral oil
and incubated for approximately 20 min, at which time 50 ll of sperm solution
was added to the mTBM containing the mature oocytes, producing a final





After sperm-oocyte coincubation, putative zygotes were washed three times
in NCSU-23 media, with glucose replaced by lactate and pyruvate [35, 38],
supplemented with 0.4% BSA and cultured at 398C, 5% CO
2
in 100 ll of the
same media under mineral oil for 48 h. Cleaved embryos were then washed and
transferred to NCSU-23 media, containing glucose, supplemented with 0.4%
BSA for further culture to the blastocyst stage [35].
DNA Extraction from Oocytes and Embryos
Oocytes/embryos were transferred individually to a 0.2-ml tube containing
20 ll ddH
2
O. The contents were then freeze–thawed twice to lyse the oocytes/




RNA Extraction from Oocytes and Embryos and Reverse
Transcription
Oocytes/embryos were transferred in groups of 5- to 0.2-ml tubes, and RNA
was extracted using the RNAqueous-Micro kit (Ambion, Huntingdon, UK)
according to the manufacturer’s instructions. RNA was reverse transcribed
using the Absolute 2-step QRT-PCR SYBR Green kit (Abgene, Epsom, UK).
The resulting cDNA was then diluted 1:5 in sterile ddH
2
O before analysis.
Generation of DNA and cDNA Standards for Real-Time PCR
The external standard of the appropriate size for each gene of interest was
generated as previously described [29] using primers designed to amplify the
specific genes (see Table 1). Reactions were performed in 20 ll using 13 PCR
buffer (Bioline, London, UK), 1.5 mM MgCl
2
(Bioline), 0.5 lM each primer,
200 lM dNTP mix (Bioline), and 2 U BioTaq polymerase (Bioline). PCR
products were run on 2% agarose gels, and DNA was extracted from the excised
bands using the QiaQuick Gel Extraction kit (Qiagen, Crawley, West Sussex,
UK) according the manufacturer’s instructions. Samples were diluted to 0.02 ng/
ll and then serially diluted 10 fold for use as standards for real-time PCR.
Real-Time PCR Quantification
Real-time PCR was performed on a Rotorgene 3000 cycler (Corbett
Research, UK) using a 72 well rotor. Reactions tubes contained 7.5 ll ABsolute
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QPCR SYBR Green Mix (Abgene), primers at optimized concentrations (see
Table 1) and 2 ll each sample or standard, made up to 15 ll with sterile ddH
2
O.
The reaction conditions were 1 cycle at 958C for 15 min followed by 50 cycles
of 948C for 10 sec, the appropriate annealing temperature (see Table 1) for 15
sec and 728C for the appropriate extension time (see Table 1), with data being
acquired at the end of the extension steps. When primer-dimers were produced,
an extra cycle and acquisition step was inserted after the extension phase. This
consisted of a 15 sec hold at the temperature just higher than that at which the
primer-dimers melted, allowing for calculations to be made that excluded
fluorescence generated by the primer-dimers [40]. The data were acquired after
primer-dimer denaturation on the FAM/SYBR channel, and a melt curve was
analyzed to check for the absence of further mispriming. All samples were run
twice in triplicate, and absolute mRNA levels per fixed number of oocytes/
embryos (n¼ 5) were calculated by the Rotorgene software (Version 6, Corbett
Research) and Microsoft Excel using the standards described above. Mean 6
SEM expression levels are presented relative to either Day 1 BCBþ oocytes or
two-cell-staged embryos, as previously described [41, 42]. This allowed all
three genes to be normalized for direct comparison of changes in expression
levels between the three genes at each of the oocyte or embryo stages.
Immunocytochemistry
Antibodies were used against the nuclear-encoded transcription and
replication regulators of mtDNA, TFAM (Santa Cruz Biotechnology, Santa
Cruz, CA) and POLG (Abcam, Cambridge, UK) and against the mitochon-
drially encoded cytochrome c oxidase I (MT-CO1) protein to demonstrate
colocalization with TFAM and POLG. Oocytes/embryos were fixed in 3.8%
formaldehyde (BDH Laboratory Supplies, Poole, Dorset, UK) for 15 min at
room temperature, permeabilized with 0.1% (v/v) Triton X100 for 5 min, and
blocked with 100 lM glycine and 2 mg/ml BSA in PBS. Primary antibody was
added at optimized concentrations (TFAM: 4 lg/ml; POLG: 20 lg/ml; MT-
CO1: 2 lg/ml), and the oocytes/embryos were incubated at 378C for 2 h.
Oocytes/embryos were then transferred to 0.1% Triton X100 for washing
before being labeled with the appropriate secondary antibodies (TFAM: 1lg/ml
Alexa Fluor 593 anti-goat immunoglobulin (Ig) G; POLG: 2 lg/ml Alexa Fluor
488 anti-rabbit IgG or 1 lg/ml Alexa Fluor 593 anti-rabbit IgG; MT-CO1: 2
lg/ml Alexa Fluor 488 anti-mouse IgG; Molecular Probes, Paisley, UK) for 1 h
at 378C. After further washing, oocytes/embryos were mounted on to slides
using Vectashield mounting medium (Vectalabs, Burlingame, CA), and viewed
using the Leica DM IRE2 confocal microscope with a Leica TCS SP2 scanner
(Leica Microsystems Ltd., Buckinghamshire, UK), as described previously
[39]. Data were analyzed using the Leica Confocal software (Leica).
Fluorescein isothiocyanate (FITC) excitation was at 488 nm, and detection
was between 500 nm and 535 nm; rhodamine excitation was at 594 nm, and
detection was between 600 nm and 700 nm. To allow for comparisons of
staining intensity following confocal microscopy, the auto gain functions were
switched off, and the same gain and photomultiplier settings were used for each
embryo. Each channel was adjusted before images were taken to remove bleed
through from other channels, and images were taken from FITC and rhodamine
channels simultaneously from the same section of the oocytes/embryos.
Western Blotting
TFAM antibody specificity was determined using Western blotting both
with and without the associated blocking peptide (Santa Cruz Biotechnology).
Protein extracted from porcine heart tissue was run on a 12% polyacrylamide
gel, alongside an SDS molecular weight marker (range ¼ 6.5–175 kDa; New
England Biolabs, Hitchin, Hertfordshire, UK), for 1 h at 140 V. Human protein
extracted from umbilical vein endothelial cells was used as a positive control.
Proteins were blotted onto Immobilon P transfer membrane (Millipore,
Billerica, MA) for 70 min at 44 mA. Membranes were blocked with 5% (w/
v) Marvel (Safeway, UK) in TBS (1.5 M NaCl, 0.2 M Tris and ddH
2
0 to 1 L,
pH 7.6) and slowly agitated for 1 h at room temperature. The blot was then
incubated with TFAM primary antibody (0.8 lg/ml), either with or without the
blocking peptide, overnight at 48C. After washing in TBS plus 0.1% [v/v]
Tween 20 (TBS-T) 5 times for 10 min each, the blot was incubated with the
secondary antibody (Rabbit anti-goat IgG conjugated to horseradish peroxi-
dase) for one hour before washing in TBS-T a further 5 times for 10 min each.
Visualization of protein bands was through the enhanced chemiluminescence
Western blotting system (Pierce Biotechnology Inc, Rockford, IL).
Statistical Analysis
Nonparametric Mann-Whitney U-tests were used to determine difference in
mtDNA copy number and mRNA levels between stages of oocyte and embryo
development, between BCBþ and BCB oocytes, and between ddC-treated and
untreated oocytes [25]. Differences in fertilization rates between ddC-treated
and untreated oocytes were determined using the Fisher exact test [39]. Groups
producing P values , 0.05 were considered significantly different.
RESULTS
Analysis of Preimplantation Porcine Embryos
In order to determine whether mtDNA replication takes place
throughout preimplantation development, we analyzed the level
of TFAM, POLG, and POLG2 mRNA from the two-cell stage
through to the expanded blastocyst. At the two-cell stage, all
three factors were expressed at extremely low levels (Fig. 1).
However, at the 4-cell stage, mRNA levels were increased for
all 3 factors, by 43-fold for TFAM (P¼0.02), 11-fold for POLG
(P . 0.05), and 48-fold for POLG2 (P ¼ 0.02). At the 8-cell
stage, TFAM mRNA levels were slightly reduced, although
POLG mRNA levels decreased to lower than those at the 2-cell
stage (P . 0.05), while POLG2 mRNA levels rose by 1.8 fold
(P. 0.05). At the 16-cell stage, TFAM mRNA levels continued
to decrease, representing a 2.6-fold decrease from the 4-cell to
TABLE 1. Primers used for real-time PCR.










TFAM CAG ACT GGC AGG TGT ACA CGA GGT CTT TTT GGT TTT CCA 54 15 400 164
POLG GAG CAT GCA CAT GGC CAT CT AGC TGC TTT CCA GCA GCA GCT 57 20 330 341
POLG2 GTG CCT TGG AGC ATT ATG TT GAA GCT TCA GTC TTT TCA CCG 54 15 400 157
mtDNA CTC AAC CCT AGC AGA AAC CA TTA GTT GGT CGT ATC GGA ATC G 56 20 330 254
FIG. 1. Expression of mtDNA replication-associated genes during
preimplantation development. Bars represent the number (mean 6 SEM)
of TFAM, POLG, and POLG2 mRNA levels in two-cell- to expanded
blastocyst-staged embryos as a proportion of those in two-cell embryos.
*Differences between the various stages of development are significant (P
 0.02).
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16-cell stages (P¼0.02). POLG2 mRNA followed suit, with an
8.8-fold decrease between 8-cell and 16-cell embryos (P ¼
0.02), while POLG mRNA levels remained low. All three
factors, particularly POLG (P¼ 0.01) and POLG2 (P¼ 0.02),
then increased their mRNA levels between 16-cell and
expanded blastocyst-staged embryos. Changes in mRNA levels
were mirrored by levels of antibody staining for POLG and
TFAM protein (Fig. 2A). This was especially so at the four-cell
stage, with increases for both TFAM and POLG proteins, and at
the morula and expanded blastocyst stages, with increases for
POLG protein. Interestingly, POLG protein was concentrated at
the outer edge of the embryo in the morulae and then throughout
the entire embryo in expanded blastocysts.
In order to confirm the specificity of the TFAM antibody, a
Western blot was carried out in which porcine (test) and human
(control) protein was incubated with the TFAM antibody,
FIG. 2. Expression of TFAM and POLG proteins during preimplantation development. A) POLG (green) and TFAM (red) protein staining patterns in
preimplantation embryos from the two-cell to the expanded blastocyst stage. Magnification3630. B) Western blot showing molecular weight marker (M),
human (H) and porcine (P) protein incubated with the TFAM antibody, and human (H-P) and porcine (P-P) protein incubated with the TFAM antibody and
its associated blocking peptide. C) Green staining in the far left panels shows MT-CO1 localization in porcine oocytes. Adjacent panels with red staining
show TFAM (top) and POLG (bottom) localization in the same oocytes. Merged images, both in full (third from left; magnification3630) and in more detail
(far right; magnification34 digital zoom) demonstrate colocalization of TFAM and POLG with MT-CO1.
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either with or without the associated blocking peptide. A band
of approximately 24 kDa, as expected for TFAM [43], was
observed in the porcine protein sample (Fig. 2B), but this was
not visible in the sample containing the blocking peptide.
Costaining of POLG and TFAM antibodies with an antibody
against MT-CO1 was also carried out. The predominantly
yellow staining in the merged images suggests that both TFAM
and POLG staining is localized to the mitochondria, further
indicating the specificity of the antibodies against these
proteins (Fig. 2C).
In order to determine whether the expression of these
proteins had a functional role, mtDNA copy number was
analyzed in whole embryos at each stage of development (Fig.
3). Mean values of 564 283 6 253 833 copies were detected in
2-cell embryos. However, a progressive decrease was then
observed, resulting in 73 561 6 28 106 copies in 4-cell
embryos (P . 0.05), and 21 104 6 8249 in 8-cell embryos
(P¼ 0.01). This was followed by an increase in mtDNA copy
number to 175 454 6 55 981 in 16-cell embryos (P ¼ 0.009
compared with 8-cell embryos), and 131 238 6 34 498 in
morulae (P¼ 0.001 compared with 8-cell embryos). A further
increase then occurred resulting in 1 254 604 6 345 329 copies
at the expanded blastocyst stage (P ¼ 0.002 compared with
morulae).
Analysis of Maturing Oocytes
In order to elucidate the mechanisms that ensure sufficient
mtDNA copy numbers are present prior to fertilization, the
expression of TFAM, POLG, and POLG2 mRNA was analyzed
in selected BCB
þ
- and BCB-selected oocytes throughout
maturation. On Day 1 of maturation, TFAM and POLG
mRNAs were present at significantly higher levels in BCB
þ
oocytes than in BCB oocytes (P  0.001 and P  0.001,
respectively; Fig. 4) and at slightly higher levels for POLG2
mRNA (Fig. 4). Throughout the maturation process, BCB
þ
oocytes demonstrated a decrease to 33% by Day 2 (P¼ 0.004)
and to 11% by Day 3 (P ¼ 0.004) for TFAM mRNA, and to
18% by Day 2 (P¼ 0.004) and to 13% by Day 3 (P¼ 0.004)
for POLG mRNA. A similar pattern was then observed for
POLG2 mRNA, with reductions to 58% by Day 2 (P . 0.05)
and to 10% by Day 3 (P ¼ 0.02 compared with Day 2).
On the other hand, BCB oocytes continued to contain
significantly lower levels of TFAM mRNA than BCBþ oocytes
on Day 2 (P¼0.04), but there was a 2.4-fold increase by Day 3
(P¼ 0.02). For POLG mRNA, there was a decrease to 31% by
Day 2 (P ¼ 0.02), followed by a 2.8-fold increase between
Days 2 and 3 (P . 0.05). For POLG2, mRNA levels on Day 2
remained similar to those on Day 1, although there was a 2.4-
fold increase in expression on Day 3, resulting in BCB
oocytes containing significantly more POLG2 mRNA than
BCB
þ
oocytes (P¼ 0.02). These changes in mRNA levels for
BCB
þ
oocytes were matched by changes in protein staining
intensity for POLG (Fig. 5) and TFAM (data not shown).
However, for BCB oocytes, POLG protein synthesis appeared
to be delayed until Day 3 (Fig. 5).
ddC Inhibition
In order to determine the importance of the last stages of
mtDNA replication for oocyte maturation, BCB
þ
and BCB
oocytes were treated with ddC, a nucleoside analogue causing
inhibition of mtDNA replication. As can be seen in Figure 4,
ddC-treated BCB
þ
oocytes had higher levels of POLG mRNA
than untreated oocytes and, by Day 3, treated oocytes
FIG. 3. MtDNA copy number in preimplantation embryos. Bars
represent mean 6 SEM mtDNA copy number in two-cell to expanded
blastocyst staged embryos. Significant differences between developmental
stages are indicated (* P  0.01; **P , 0.005).
FIG. 4. Expression of mtDNA replication-associated genes during oocyte
IVM. Bars represent the number (mean 6 SEM) of TFAM, POLG, and
POLG2 mRNA copies in oocytes matured with and without ddC.
Significant differences between groups are indicated (*P , 0.05, ** P ,
0.01, ***P  0.005).
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contained significantly more POLG mRNA than untreated
oocytes (P ¼ 0.007; Fig. 4). However, in ddC-treated BCB
oocytes, POLG mRNA levels began to increase earlier than in
the untreated BCB oocytes, resulting in significantly higher
mRNA levels on Day 2 (P¼0.006) and Day 3 (P¼0.006) than
in untreated oocytes. The effect of ddC treatment was also
reflected in POLG protein expression patterns (Fig. 5).
Interestingly though, ddC-treated BCB
þ
oocytes maintained
their expression of POLG protein throughout the oocyte from
Days 1 to 3, while the untreated oocytes localized to the outer
edges of the oocyte on Day 3 (Fig. 5). Unexpectedly, ddC-
treated BCB oocytes on Day 3 did not demonstrate an
increase in POLG protein to the extent observed in the
untreated oocytes, despite higher levels of mRNA being
present.
Treatment with ddC on maturing BCB
þ
oocytes also
resulted in a significantly greater reduction in TFAM mRNA
levels throughout the maturation process than that observed in
untreated BCB
þ
oocytes (Day 2: P¼ 0.006; Day 3: P¼ 0.004;
Fig. 4). In contrast, ddC-treated BCB oocytes demonstrated
no significant change in TFAM mRNA levels between Day 1
and Day 2, as was the case for untreated BCB oocytes.
However, by Day 3, there was a significant decrease in TFAM
mRNA (P¼ 0.006) to 8% of the level present on Day 1. This is
in contrast to the increase observed in untreated oocytes at this
stage. Day 3 ddC-treated BCB oocytes also lacked the
increased TFAM protein observed in the untreated oocytes
(data not shown).
POLG2 mRNA in BCBþ oocytes treated with ddC followed
a similar pattern to that of the untreated oocytes on Day 2.
However, by Day 3, there was a 22-fold increase in POLG2
mRNA levels (P¼ 0.04), resulting in these oocytes containing
more POLG2 mRNA than the untreated oocytes (P . 0.05).
BCB oocytes treated with ddC throughout the maturation
process also demonstrated slightly increased levels of POLG2
mRNA compared with untreated BCB oocytes.
Analysis of mtDNA copy number was carried out to
determine whether oocyte mtDNA content was affected. BCB
þ
oocytes contained 403 113 6 80 314 mtDNA copies on Day 1
(Fig. 6), which decreased to 165 362 6 30 461 on Day 2 (P .
0.05), followed by an increase to 323 038 6 71 650 on Day 3
(P . 0.05). BCB oocytes contained significantly fewer
mtDNA copies on Day 1 (66 781 6 8587; P , 0.001) and Day
2 (68 406 6 13 733; P ¼ 0.001). However, a 7-fold increase
resulted in 503 263 6 193 295 copies being present on Day 3
(P ¼ 0.02). BCBþ oocytes treated with ddC decreased their
mtDNA copy number on Day 2 to 92 857 6 20 160 (P¼ 0.04),
and then to 20 160 6 4625 on Day 3 (P , 0.001), resulting in
these oocytes containing significantly fewer mtDNA molecules
than the untreated oocytes (P , 0.001). BCB oocytes treated
with ddC also decreased their mtDNA copy number during
maturation, with 9925 6 2949 copies present on Day 2 (P ,
0.001) and 35 848 6 15 803 on Day 3 (P , 0.001), again with
Day 3 treated oocytes containing significantly fewer mtDNA
copies than the untreated oocytes (P , 0.001).
Analysis of Fertilization Ability of ddC-Treated Oocytes
There was no significant difference in fertilization outcome
between ddC-treated and untreated BCB
þ
oocytes. However,
those ddC-treated oocytes that were able to fertilize did not
develop beyond the six-cell stage. MtDNA copy number was,
therefore, analyzed in these early embryos in order to
determine whether a lack of mtDNA copies was responsible
for their developmental arrest. Two-cell embryos derived from
ddC-treated oocytes contained 185 234 6 49 874 copies of
mtDNA, only slightly less than 2-cell embryos derived from
FIG. 5. Localization of POLG protein during oocyte maturation. Images show the localization of POLG protein in BCBþ (top row) and BCB (bottom
row) oocytes on Day 1, Day 2 (untreated and ddC treated), and Day 3 (untreated and ddC treated). Magnification3630.
FIG. 6. MtDNA copy number in maturing oocytes. Bars represent mean
6 SEM mtDNA copy number in maturing oocytes. Significant difference
in mtDNA between two groups are indicated (* P , 0.05; ** P , 0.01;
*** P  0.001).
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untreated oocytes (P . 0.05). However, this was significantly
higher than in Day 3 oocytes treated with ddC (P , 0.001),
indicating that mtDNA replication had occurred at fertilization.
As with embryos derived from untreated oocytes, mtDNA copy
number then decreased to 106 692 6 28 497 for 4-cell embryos
(P . 0.05) and 4804 6 1092 for 6-cell embryos (P , 0.001).
These values were not significantly different from their
respective, untreated four-cell and eight-cell counterparts.
DISCUSSION
ATP is vital for preimplantation development. In mammals,
such as the pig [44], cow [45], rat [46], mouse [47], and human
[48], the requirement for ATP generated through OXPHOS
decreases as the preimplantation embryo develops. Conse-
quently, there is a greater dependence on glycolysis [49]. Once
at the blastocyst stage, the requirement for OXPHOS then
increases [50], coinciding with the increased mitochondrial
metabolism detected in mouse trophectoderm (TE) cells [51]. It
is apparent from both this study in the pig, and in cattle [25],
that the requirement for OXPHOS-derived ATP mirrors the
initial decline and subsequent increases in mtDNA copy
number. Similarly, somatic cells with reduced mtDNA content,
such as aged cells with accumulated mtDNA deletions [52],
various cancer cells [53], and cells lacking TFAM [54],
demonstrate reduced mitochondrial ATP production and
increased dependence on glycolysis. This clearly demonstrates
the relationship between mtDNA copy number and mitochon-
drial ATP production.
The marked increase in mtDNA copy number observed at
the expanded blastocyst stage (Fig. 3) coincided with the
increased transcription of POLG and POLG2 genes (Fig. 1)
and increased translation of POLG (Fig. 2A). Increased POLG
protein was observed in morulae localized to the outer edges of
the embryos, the region likely representing cells destined to
become TE (Fig. 2A). Increased POLG protein was not
detected in the inner embryo, representing cells of the ICM,
until the expanded blastocyst stage. This might suggest that
mtDNA replication occurs first in the TE and then in the ICM.
Again, this is consistent with the recent analysis of mouse
blastocyst metabolism, where TE cells were determined to have
increased oxygen consumption, increased ATP production, and
increased mitochondrial number relative to cells of the ICM
[51]. This would account for the high mtDNA copy numbers
detected in our study and those observed in the mouse [24] and
cattle [25]. Indeed, undifferentiated embryonic stem cells,
which are derived from the ICM, are known to contain low
numbers of mitochondria [27, 55] and low levels of mtDNA
transcription and replication factor expression [27]. Despite a
small but consistent increase in TFAM gene transcription from
morula to expanded blastocyst, TFAM protein was present at
very low levels throughout the cytoplasm, even at the expanded
blastocyst stage. This would suggest that only low levels are
necessary for mtDNA replication. The levels of porcine TFAM
mRNA are consistent with increases observed at the morula
and blastocyst stages in mouse [24] and cow [25] embryos,
although these studies did not include analysis of the TFAM
protein.
The discreet early burst of POLG expression observed here
at the four-cell stage and the mtDNA replication observed at
the two-cell stage in the mouse [26] coincides with embryonic
genome activation (EGA), which occurs at the four-cell stage
in pigs [56] and the two-cell stage in mouse [57]. In cattle,
upregulation of TFAM and NRF1 expression at the 8- to 16-cell
stage [25] also coincides with EGA taking place at the 16-cell
stage [58]. Although no cumulative increase in mtDNA copy
number was recorded as a result of these activities, this
mechanism could act to replenish degraded copies [26].
However, this activity might merely be explained by the
generic expression of a whole host of genes at this one
particular stage in development [59] rather than a specific
mechanism to drive mtDNA replication.
As embryo mtDNA copy number decreased by 60% from
the 2-cell to the 4- to 8-cell stage in cattle [25], and by 96%
from the 2-cell to the 8-cell stage in the pig, this suggests the
presence of an active mtDNA degradation process. A decrease
in mtDNA copy number to critical levels at the eight-cell stage
suggests that the mtDNA copy number present at fertilization is
an important investment for subsequent developmental success.
This is demonstrated by the decreased fertilization outcome of
BCB oocytes and ddC-treated oocytes, both of which
contained decreased mtDNA levels compared with untreated
BCB
þ
oocytes. This supports the hypothesis that a minimum
mtDNA threshold exists for development to ensue [30]. This
would further support the rationale behind cytoplasmic
supplementation, instigated to overcome developmental arrest
in oocytes from older women [60], although its clinical use is
confounded by other outcomes [61, 62]. Indeed, supplemen-
tation with pure populations of mitochondria from BCB
þ
oocytes into BCB oocytes again suggests that appropriate
numbers of mtDNA copies are a determiner of oocyte
competence [29]. Consequently, prefertilization mitochondrial
biogenesis is critical. This is best exemplified by the large
increase in mtDNA replication during oogenesis observed in
many species in preparation for fertilization. For example, there
is a 45-fold increase in cattle mtDNA copy number from the
primordial germ cell stage to preovulating oocytes [19]. In the
human, premigratory primordial germ cells contain approxi-
mately 10 mitochondria per cell [18], and increase to 700 000
in mature oocytes [30, 31], with similar results having been
reported in pigs [29].
We have now carried out the first analysis of mtDNA copy
number throughout IVM, using both competent (BCB
þ
) and
less competent (BCB) oocytes, to test the hypothesis that
mtDNA replication is either delayed or compromised in less
competent oocytes. Previous studies have indicated that BCB
þ
oocytes tend to fertilize more readily [29, 33] and also have
higher numbers of mtDNA copies at Day 2 of maturation [29].
In this study, less competent BCB oocytes exhibited a delay
in mtDNA replication due to the delayed onset of expression of
their nuclear-encoded replication factors. For example, repli-
cation factor expression decreased during IVM in the BCB
þ
oocytes, and mtDNA copy number was higher in these oocytes
than in BCB oocytes on Days 1 and 2, suggesting that the
major increase in mtDNA copy number had already occurred
by this time. However, BCB oocytes increased their
expression of replication factors during oocyte maturation,
and a sharp increase in mtDNA copy number was observed on
Day 3, suggesting that the majority of mtDNA replication in
these oocytes was occurring during the IVM period.
Although we observed a decrease in mtDNA copy number
in BCB
þ
oocytes from Day 1 to Day 2, followed by an increase
to Day 3, these differences were not statistically significant. To
determine whether an active replication process was taking
place, oocytes were treated with ddC, the antiretroviral
nucleoside analogue that inhibits mtDNA replication [37].
The initial decline in mtDNA copy number between Days 1
and 2 was more severe than for untreated oocytes, and the
tendency for an increase in mtDNA copy number between
Days 2 and 3 was lost. This resulted in a further 75% decrease
in mtDNA copy number over the maturation period in those
oocytes treated with ddC. Consequently, this would suggest
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that, in untreated oocytes, mtDNA replication was still taking
place during the later stages of maturation in order to replenish
degraded mtDNA molecules. Indeed, accumulation of mtDNA
deletions has also been demonstrated during oocyte maturation
in the rhesus macaque [63], again supporting the concept of
discreet levels of mtDNA replication taking place.
The loss of mtDNA copies following ddC treatment is
comparable to human MOLT T-lymphoblastic cells which,
following 48 h of ddC treatment, decreased their mtDNA copy
number 5-fold [64]. To compensate, these cells upregulated
glycolysis following the mtDNA loss, producing increased
levels of lactate after 72 h. Increased lactate production was
also noted in rat PC12 cells after 48 h of ddC treatment [65].
However, at the transcriptional and translational level, we
noted a further response to ddC inhibition of mtDNA
replication. This involves the increased transcription of the
POLG and POLG2 genes, and also the maintenance of the
POLG protein in BCB
þ
oocytes. Similarly, BCB oocytes
increased expression of TFAM and POLG protein in the later
stages of IVM and, as a consequence, increased mtDNA copy
number late in the maturation process. This suggests the
presence of a feedback mechanism for maintaining sufficient
mtDNA copies to support fertilization. MtDNA depletion due
to ddC has previously been reported to initiate a feedback
increase in TFAM expression [66], although effects on POLG
expression were not analyzed.
Due to insufficient mtDNA levels on Day 3, we had
anticipated that ddC-treated oocytes would have reduced
fertilization rates. However, fertilization rates for ddC-treated
and untreated oocytes were similar (P . 0.05). Furthermore,
analysis of mtDNA copy number in early embryos showed
similar copy numbers to those in embryos derived from
untreated BCB
þ
oocytes. As the ddC-treated oocytes contained
significantly fewer mtDNA copies than untreated oocytes at
insemination, significantly increased rates of mtDNA replica-
tion must have occurred just prior to fertilization, when the ddC
was removed. This was most likely facilitated by the increased
production of POLG and POLG2 mRNA in ddC-treated oocytes
during the later stages of maturation. Interestingly, we did not
observe an increase in TFAM mRNA following ddC treatment,
again suggesting that minimum levels of TFAM protein were
sufficient for increased replication to take place. However,
despite the apparently normal fertilization ability of ddC-treated
oocytes, the resulting embryos did not develop beyond the four-
to six-cell stage. This provides further evidence for a minimum
mtDNA copy number requirement [29, 30] at a checkpoint
during oocyte maturation, and for the necessity of subsequent
time-specific downregulation of mtDNA replication to allow for
successful preimplantation development.
In conclusion, we propose that the majority of mtDNA
replication and the expression of the relevant transcription and
replication factors are terminated prior to Days 1–3 of IVM in
those oocytes likely to fertilize and develop. In incompetent
oocytes, mtDNA replication is delayed, and the oocyte attempts
to rescue this during the final stages of maturation. Conse-
quently, oocyte competence in terms of mtDNA replication and
composition is not fully synchronized, and will result in either
failed fertilization or developmental arrest. This further
indicates that mtDNA differentiation is one of the final markers
of cellular differentiation and is critical to cellular function.
Such outcomes have implications for those investigators
choosing oocytes for a variety of reconstruction protocols.
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